Hypoxia-preconditioned mesenchymal stem cells attenuate peritoneal adhesion through TGF-β inhibition

Main Article Content

Setyo Trisnadi
Adi Muradi Muhar
Agung Putra
Azizah Retno Kustiyah


Peritoneal adhesions (PAs) are generally described as fibrous bands between intra-abdominal organs following an abdominal surgical operation. The definitive treatments of PAs are currently ineffective yet. Hypoxia-mesenchymal stem cells (H-MSCs) have a higher capability to survive at the site of injury than normoxia-MSCs (N-MSCs) to repair injured tissue without fibrosis. This study aimed to analyze the effect of H-MSCs in controlling formation of PAs by reducing TGF-β level in a rat model.

A study of post-test only control group design was conducted, involving eighteen PA rat models weighing 250 ± 25 g that were randomly assigned into 3 groups, comprising control group (C), and groups T1 and T2 receiving H-MSC treatment at doses of 3 x 106 and 1.5 x 106, respectively. To induce H-MSCs, MSCs were incubated in hypoxic conditions at 5% O2 and 37oC for 24 hours. Expression level of TGF-β was analyzed by enzyme-linked immunosorbent assay (ELISA) at 450 nm and adhesion formation was described macroscopically. The Kruskal-Wallis variance analysis was used to analyze significant differences among the groups.

The results of this study showed that H-MSCs in group T1 inhibited TGF-β expression significantly on day 8 (p<0.001) and day 14 (p<0.05). Moreover, there was almost no adhesion apparent following H-MSC administration in group T1.

Based on this study, we conclude that H-MSCs may attenuate PA formation following inhibition of TGF-β expression in the PA rat model.

Article Details

How to Cite
Trisnadi, S., Muhar, A. M., Putra, A., & Kustiyah, A. R. (2020). Hypoxia-preconditioned mesenchymal stem cells attenuate peritoneal adhesion through TGF-β inhibition. Universa Medicina, 39(2), 97–104. https://doi.org/10.18051/UnivMed.2020.v39.97-104
Original Articles


Tabibian N, Swehli E, Boyd A, Umbreen A, Tabibian JH. Abdominal adhesions: a practical review of an often overlooked entity. Ann Med Surg (Lond) 2017;15:9–13. doi: 10.1016/j.amsu.2017.01.021.

Arung W, Meurisse M, Detry O. Pathophysiology and prevention of postoperative peritoneal adhesions. World J Gastroenterol 2011;17:4545–53. doi: 10.3748/wjg.v17.i41.4545.

Wang G, Wu K, Li W, et al. Cross talk between IL‐17 and TGF‐β. Wound Repair Regen 2014;22: 631-9. doi: 10.1111/wrr.12203.

Rocca A, Aprea G, Surfaro G, et al. Prevention and treatment of peritoneal adhesions in patients affected by vascular diseases following surgery: a review of the literature. Open Med (Wars) 2016;11:106–14. doi: 10.1515/med-2016-0021.

Yao S, Tanaka E, Matsui Y, et al. Does laparoscopic adhesiolysis decrease the risk of recurrent symptoms in small bowel obstruction? A propensity score-matched analysis. Surg Endosc 2017;31:5348. https://doi.org/10.1007/s00464-017-5615-9.

Glenn JD, Whartenby KA. Mesenchymal stem cells: emerging. mechanisms of immunomodulation and therapy. World J Stem Cells 2014;6:526–39. doi: 10.4252/wjsc.v6.i5.526.

Maleki M, Ghanbarvand F, Behvarz MR, Ejtemaei M, Ghadirkhomi E. Comparison of mesenchymal stem cell markers in multiple human adult stem cells. Int J Stem Cells 2014;7:118-26. http://dx.doi.org/10.15283/ijsc.2014.7.2.118.

Raoufi MF, Tajik P, Dehghan MM, Eini F, Barin A. Isolation and differentiation of mesenchymal stem cells from bovine umbilical cord blood. Reprod Domest Anim 2011;46:95-9. doi: 10.1111/j.1439-0531.2010.01594.x .

Yustianingsih V, Sumarawati T, Putra A. Hypoxia enhances self-renewal properties and markers of mesenchymal stem cells. Univ Med 2019;38:164-71. doi: 10.18051/UnivMed.2019.v38.156-163.

Salazar‐Noratto GE, Luo G, Denoeud C, et al. Concise review: understanding and leveraging cell metabolism to enhance mesenchymal stem cell transplantation survival in tissue engineering and regenerative medicine applications. Stem Cells 2020;38:22–33. doi: 10.1002/stem.3079.

Lotfinia M, Lak S, Mohammadi Ghahhari N, et al. Hypoxia pre-conditioned embryonic mesenchymal stem cell secretome reduces IL-10 production by peripheral blood mononuclear cells. Iran Biomed J 2017;21:24–31. doi: 10.6091/.21.1.24.

Caja L, Dituri F, Mancarella S, et al. TGF-β and the tissue micro environment : relevance in fibrosis and cancer. Int J Mol Sci 2018;19:1294. https://doi.org/10.3390/ijms19051294 PMid:29701666.

Bobyleva PI, Andreeva ER, Gornostaeva AN, Buravkova LB. Tissue-related hypoxia attenuates proinflammatory effects of allogeneic PBMCs on adipose-derived stromal cells in vitro. Stem Cells Int 2016;2016:4726267. doi: 10.1155/2016/4726267.

Muhar AM, Putra A, Warli SM, Munir D. Hypoxia-mesenchymal stem cells inhibit intra-peritoneal adhesions formation by upregulation of the IL-10 expression. Maced J Med Sci 2019;7:3937‐43. doi: 10.3889/oamjms.2019.713.

Charan J, Kantharia ND. How to calculate sample size in animal studies?. J Pharmacol Pharmacother 2013;4:303-6. doi:10.4103/0976-500X.119726.

Karaca G, Pehlivanli F, Aydin O, et al. The effect of mesenchymal stem cell use on intraabdominal adhesions in a rat model. Ann Surg Treat Res 2018;94:57-62. https://doi.org/10.4174/astr.2018.94.2.57.

Moris D, Chakedis J, Rahnemai-Azar AA, et al. Postoperative abdominal adhesions: clinical significance and advances in prevention and management. J Gastrointest Surg 2017;21:1713–22. https://doi.org/10.1007/s11605-017-3488-9.

Wei G, Chen X, Wang G, et al. Inhibition of cyclooxygenase-2 prevents intra-abdominal adhesions by decreasing activity of peritoneal fibroblasts. Drug Des Devel Ther 2015;9:3083–98. doi: 10.2147/DDDT.S80221.

Wang G, Wu K, Li W, et al. Cross talk between IL‐17 and TGF‐β. Wound Repair Regen 2014;22: 631-9. doi: 10.1111/wrr.12203.

Yang B, Gong C, Qian Z, et al. Prevention of post-surgical abdominal adhesions by a novel biodegradable thermosensitive PECE hydrogel. BMC Biotechnol 2010;10:65. doi:10.1186/1472-6750-10-65.

Wang N, Shao Y, Mei Y, et al. Novel mechanism for mesenchymal stem cells in attenuating peritoneal adhesion: accumulating in the lung and secreting tumor necrosis factor α-stimulating gene-6. Stem Cell Res Ther 2012;3:51. doi: 10.1186/scrt142.

Lv B, Li F, Fang J, et al. Hypoxia inducible factor 1α promotes survival of mesenchymal stem cells under hypoxia. Am J Transl Res 2017;9:1521-9.

Kraemer B, Wallwiener C, Rajab TK, Brochhausen C, Wallwiener M, Rothmund R. Standardised models for inducing experimental peritoneal adhesions in female rats. Biomed Res Int 2014:435056. doi: 10.1155/2014/435056.

Wang N, Li Q, Zhang L, et al. Mesenchymal stem cells attenuate peritoneal injury through secretion of TSG-6. PLoS One 2012;7:e43768. doi:10.1371/journal.pone.0043768.

Desai VD, Hsia HC, Schwarzbauer JE. Reversible modulation of myofibroblast differentiation in adipose-derived mesenchymal stem cells. PLoS One 2014;9:e86865. doi:10.1371/journal.pone.0086865.

Liu YY, Chiang CH, Hung SC, et al. Hypoxia-preconditioned mesenchymal stem cells ameliorate ischemia/reperfusion-induced lung injury. PLoS One 2017;12:e0187637. doi: 10.1371/journal.pone.0187637.

Branchett WJ, Lloyd CM. Regulatory cytokine function in the respiratory tract. Mucosal Immunol 2019;12:589-600. doi: 10.1038/s41385-019-0158-0.

Pakyari M, Farrokhi A, Maharlooei MK, Ghahary A. Critical role of transforming growth factor beta in different phases of wound healing. Adv Wound Care 2013;2:215–24. doi:10.1089/wound.2012.0406 .

Mutsaers SE, Prele CMA, Pengelly S, Herrick SE. Mesothelial cells and peritoneal homeostasis. Fertil Steril 2016;106:1018-24. doi: 10.1016/j.fertnstert.2016.09.005.

Schlosser K, Wang JP, Dos Santos C, et al. Effects of mesenchymal stem cell treatment on systemic cytokine levels in a phase 1 dose escalation safety trial of septic shock patients. Crit Care Med 2019;47:918–25. doi:10.1097/CCM.0000000000003657.

Filová E, Brynda E, Riedel T, et al. Improved adhesion and differentiation of endothelial cells on surface-attached fibrin structures containing extracellular matrix proteins. J Biomed Mater Res A 2014;102:698-712. doi:10.1002/jbm.a.34733.